Home > Insider Trading > Filing (0001179110-15-006376)

Filing Details

Accession Number:: 0001179110-15-006376
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-04-16 17:17:01
Reporting Period:: 2015-04-14

Filing Date:: 2015-04-16
Accepted Time:: 2015-04-16 17:17:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
916085	Health Net Inc	HNT	Hospital & Medical Service Plans (6324)	954288333

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1213947	James Woys	21650 Oxnard Street Woodland Hills CA 91367	Evp, Cfo And Coo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-04-14	17,000	$32.59	380,012	No	4	M	Direct
Common Stock	Disposition	2015-04-14	17,000	$57.93	363,012	No	4	S	Direct
Common Stock	Acquisiton	2015-04-15	17,000	$32.59	380,012	No	4	M	Direct
Common Stock	Disposition	2015-04-15	12,100	$56.50	367,912	No	4	S	Direct
Common Stock	Disposition	2015-04-15	3,900	$57.77	364,012	No	4	S	Direct
Common Stock	Disposition	2015-04-15	1,000	$58.32	363,012	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2015-04-14	17,000	$0.00	17,000	$32.59
Common Stock	Stock Option (Right to Buy)	Disposition	2015-04-15	17,000	$0.00	17,000	$32.59

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
49,000		2015-05-13	No	4	M	Direct
32,000		2015-05-13	No	4	M	Direct

Footnotes

Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on May 13, 2005 under the Issuer's 2005 Long-Term Incentive Plan, as amended (the "2005 Grant"), in a transaction exempt under Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Act"). The exercise of the 2005 Grant was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
Includes 5,450 shares in which the Reporting Person has a beneficial interest under the profit-sharing component of the Issuer's 401(k) Savings Plan.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.69 to $58.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $56.14 to $57.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.19 to $58.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.21 to $58.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
The 2005 Grant became exercisable in 25% increments on each of the first, second, third, and fourth anniversaries of May 13, 2005, the grant date.